Eighth Annual UCI Hematology Symposium

Purpose

The Eighth Annual Hematology Symposium will feature regional and national experts bringing you state-of-the-art updates on CLL, Hemorrhagic Shock and Resuscitation, Hemostasis Testing and ROTEM, RN/NP Considerations in Hematology/Oncology Transplant, Updates in Multiple Myeloma, Autologous and Allogeneic HSCT, Hyperhaemolysis and other TM Considerations in SCD, and updates in Sickle Cell Disease.

Target Audience

This activity was developed for primary care physicians, nurses, nurse practitioners, physician assistants, and other professionals with an interest in hematology.

Activity Objectives

• As a result of attending this course, I am better able to recognize emerging options in the management of sickle cell disease.
• Use of antifibrinolytics is indicated when ROTEM tracings demonstrate hyperfibrinolysis in a bleeding patient.
• As a result of attending this course, I am better able to recognize the role of Hematopoietic Stem Cell Transplant and Cellular Therapies in selected states.

Attendance & Evaluation for CME Credit

In order to account for attendance and receive CME credit for participating in-person or Zoom, please click on this link (coming soon) and complete the evaluation.

Evaluation links will close on Sunday, November 12, 2023 at 11:00pm

Full disclosure information from all those in control of content will be provided in advance of the activity.

Accreditation Statement 

The University of California, Irvine School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Designation Statement 

The University of California, Irvine School of Medicine designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Full disclosure information from all those in control of content will be provided in advance.